Regulatory Compliance and
Gap Analysis

X Pharma Plus delivers expert gap analysis services to identify and resolve regulatory gaps, ensuring compliance and accelerating product approvals.

Regulatory Compliance and
Gap Analysis – Overview

Regulatory compliance and gap analysis are essential for the successful registration of medicinal products. While most Health Authorities (HAs) accept applications in the CTD format, the content requirements for each section may vary. Conducting a thorough regulatory gap analysis and technical assessment of supporting documents helps manufacturers identify and address gaps before submission, reducing the risk of rejections and minimizing critical queries, thereby accelerating approvals.

Evaluating legacy dossiers against current manufacturing and regulatory practices ensures compliance and highlights areas requiring mitigation. Addressing these gaps proactively—through supplements or variations—prevents non-compliance issues. X Pharma Plus, with its experienced regulatory affairs and CMC experts, provides comprehensive regulatory gap analysis support to help sponsors achieve smooth, timely product approvals.

Regulatory Compliance and Gap Analysis

“A systematic review to ensure products meet regulatory requirements and identify areas needing improvement before submission.”

  • Evaluation of regulatory submission strategies to ensure alignment with global requirements
  • Gap analysis of supporting documents and data generated during product development
  • Review of qualitative and quantitative product compositions for regulatory acceptability
  • Verification of impurity limits in accordance with ICH guidelines and Maximum Daily Dosage (MDD)
  • Regulatory assessment of protocols and reports for product development, process validation, stability programs, exhibit batches, registration batch sizes, and hold-time studies
  • Guidance on dissolution method selection and parameters
  • Assessment of biowaiver criteria for applicable products
  • Evaluation of existing dossiers for market expansion
  • Identification of region-specific stability study and compliance requirements
  • Gap analysis of draft CTD packages for submissions such as INDs, IMPDs, CTAs, NDAs, MAAs, DMFs, and Dossiers
  • Technical review and regulatory assessment of change controls
  • Regulatory gap analysis and strategic recommendations for variation/supplement submissions
  • Proactive gap analysis minimizes critical queries and accelerates regulatory approvals.
  • Ensures alignment with evolving international regulatory standards and region-specific requirements.
  • Identifies and resolves deficiencies early, preventing costly delays and non-compliance issues.

Subscribe for Updates